IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
Please read the following notice carefully before deciding whether to click on the link below to view the information on this web page.
SAEL Industries Limited (the “Company”) and Ambit Private Limited do not accept any responsibility for any contravention of applicable securities laws and regulations by individuals as a result of false information provided by such individuals.
The following disclaimer applies to the draft red herring prospectus dated November 3, 2025 (“DRHP”) of the Company filed with Securities and Exchange Board of India (“SEBI“), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”), the corrigendum to the DRHP dated January 8, 2026 (“Corrigendum”) and the addendum to the DRHP dated February 22, 2026 (“Addendum”) hosted on this website in connection with the proposed initial public offering of equity shares of face value of ₹ 5 each (“Equity Shares”) of the Company comprises a fresh issue of such number of Equity Shares by the Company aggregating up to ₹37,500.00 million (“Fresh Issue”) and an offer for sale of up to such number of Equity Shares aggregating up to ₹8,250.00 million by Norfund (the “Investor Selling Shareholder”, and such offer for sale, the “Offer for Sale” and together with the Fresh Issue, the “Offer”), whereby ICICI Securities Limited, Kotak Mahindra Capital Company Limited, JM Financial Limited and Ambit Private Limited (“BRLMs”). The DRHP, the Corrigendum and the Addendum have been made available on this website in electronic form as prescribed under Regulation 26 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP, the Corrigendum and the Addendum. By accessing the DRHP, the Corrigendum and the Addendum, you agree to follow the following terms and conditions, including any modifications to them from time to time. Access to the DRHP, the Corrigendum and the Addendum does not constitute a recommendation by the Company or any other person to subscribe to the Equity Shares offered in the Offer.
The contents of the DRHP, the Corrigendum and the Addendum are for your information only and you acknowledge that access to the DRHP, the Corrigendum and the Addendum is intended for use by you only and you agree not to forward the DRHP, the Corrigendum and the Addendum on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents herein shall be copied or duplicated in any form by any means or redistributed and in particular, may not be forwarded to any person in the United States or to any U.S. address. Any forwarding, distribution or reproduction of the contents herein in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the U.S. Securities Act of 1933, as amended (the “Securities Act”) or the applicable laws of other jurisdictions. The Company, the BRLMs and/or any of their respective affiliates, or their respective directors, officers and employees (together, the “Affiliates“) are not soliciting any action based on it, and it should not be construed as an offer to sell or the solicitation of any offer to buy or subscribe for any security and should not be construed as such. The DRHP, the Corrigendum and the Addendum do not amount to, or are not intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the SEBI ICDR Regulations, and nothing in the DRHP, the Corrigendum and the Addendum constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. Neither the Company, the BRLMs nor their respective affiliates represent that the contents of the DRHP, the Corrigendum and the Addendum herein are accurate or complete. The information contained herein has not been and will not be updated since its original publication date and may not reflect the latest updates.
The information in this section is directed at, and is intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this section. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The DRHP, the Corrigendum and the Addendum are not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the BRLMs or any of their respective Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The information furnished on the following web pages contains information intended only for persons not located in any jurisdiction where the distribution of such information is prohibited or restricted, including the United States, Canada, United Kingdom, Australia and Japan. This information is not to be furnished or made available to any person in the United States, Canada, United Kingdom, Australia or Japan or to any person to whom it is unlawful to furnish or make available such information.
The information on the following web pages is intended solely to provide background information on the Company and does not constitute, or form a part of, and should not be construed as, an offer to sell or issue or the solicitation of an offer to buy or acquire, any shares or other securities of the Company in any jurisdiction, including in the United States, and is not for publication, release or distribution in the United States. The shares or other securities of the Company have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state of other jurisdiction in the United States, and may not be offered, sold, pledged or otherwise transferred except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Neither the information on the following web pages nor any copy of any of it may be taken or transmitted into the United States, Canada, United Kingdom, Australia or Japan or distributed, directly or indirectly, in the United States, Canada, United Kingdom, Australia or Japan or to any resident thereof.
The Company and the BRLMs have taken all necessary steps to ensure that the contents of the DRHP, the Corrigendum and the Addendum as appearing on this website are identical to the DRHP filed with SEBI and the Stock Exchanges and the Corrigendum and the Addendum. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither the Company, the BRLMs nor any of their respective Affiliates accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Neither the Company, the BRLMs nor any of their respective Affiliates will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials. These materials are being made available on this website to comply with SEBI ICDR Regulations. Investors should read the DRHP, the Corrigendum and the Addendum and seek professional advice before taking any action.
Any person into whose possession the DRHP, the Corrigendum and the Addendum comes is required to inform himself or herself about and to observe any such restrictions. The Company and the BRLMs are not soliciting any action based on the DRHP, the Corrigendum and the Addendum, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities by the Company, or any of the BRLMs. Potential investors should not rely on the DRHP, the Corrigendum and the Addendum for any investment decision. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see “Risk Factors” section of the red herring prospectus, which may be filed with the Registrar of Companies, Punjab and Chandigarh at Chandigarh (“RoC”) in the future. Any decision on whether to invest in the Equity Shares described in the DRHP, the Corrigendum and the Addendum may only be made after a red herring prospectus has been filed with the RoC and must be made solely on the basis of such red herring prospectus as there may be material changes in the red herring prospectus versus the DRHP, the Corrigendum and the Addendum. Invitations to subscribe to or purchase the equity shares in the Offer will be made only pursuant to the red herring prospectus if the recipient is in India or the preliminary offering memorandum for the Offer, which comprises the red herring prospectus and the preliminary international wrap for the Offer, if the recipient is outside India. No person outside India is eligible to bid for equity shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which shall contain the selling restrictions for the Offer outside India. For details, potential investors should refer to the red herring prospectus, including the section titled “Risk Factors”, when available.
The link to the audiovisual film of the Company (“IPO AV”) is being made available on this website in accordance with the SEBI master circular number HO/49/14/14(2)2026-CFD-POD2/I/4518/2026 dated February 9, 2026, issued by the Securities and Exchange Board of India. Such materials are not directed at or intended to be accessed by persons located outside India. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or any advice or recommendation to buy, or sell or transact in any securities of the Company in the United States or in any other jurisdiction, including without limitation, India. The IPO AV provides only the salient features of the Offer and accordingly, potential investors should not rely on the IPO AV. Any decision on whether to invest in the equity shares must be made solely on the basis of the red herring prospectus.
Investors are advised not to rely on any other document, content or information provided on the Offer on the internet / online websites/ social media platforms / micro-blogging platforms and by the influencers since the same is not authorized/ approved/ commissioned/ paid by the Company or its promoter(s)/directors/Key Managerial Personnel in any manner. Any such posts, including on social media platforms, may be illegal in certain jurisdictions and only certain categories of persons may be authorized to access such information. Such posts, including on social media platforms, do not constitute an offer or solicitation of an offer, or any advice or recommendation to purchase, sell or transact in any of the Company’s securities.
The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking by the Company or Ambit Private Limited to post any such amendments or supplements on this website. The Company and the BRLMs cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the DRHP, the Corrigendum and the Addendum beyond the dates of the DRHP, the Corrigendum and the Addendum. You are accessing the website of the BRLMs at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company, the BRLMs, nor any of their Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.
Please note that application forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to the Company, the BRLMs or any of their respective Affiliates. Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions.